334 related articles for article (PubMed ID: 15476704)
1. Preserved ipsilateral-to-lesion motor map organization in the unilateral 6-OHDA-treated rat model of Parkinson's disease.
Metz GA; Piecharka DM; Kleim JA; Whishaw IQ
Brain Res; 2004 Nov; 1026(1):126-35. PubMed ID: 15476704
[TBL] [Abstract][Full Text] [Related]
2. A golgi analysis of cortical pyramidal cells in the unilateral parkinson rat: absence of change in the affected hemisphere vs hypertrophy in the intact hemisphere.
Miklyaeva EI; Whishaw IQ; Kolb B
Restor Neurol Neurosci; 2007; 25(2):91-9. PubMed ID: 17726267
[TBL] [Abstract][Full Text] [Related]
3. Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease.
Ogura T; Ogata M; Akita H; Jitsuki S; Akiba L; Noda K; Hoka S; Saji M
Neurosci Res; 2005 Mar; 51(3):299-308. PubMed ID: 15710494
[TBL] [Abstract][Full Text] [Related]
4. Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice.
Iancu R; Mohapel P; Brundin P; Paul G
Behav Brain Res; 2005 Jul; 162(1):1-10. PubMed ID: 15922062
[TBL] [Abstract][Full Text] [Related]
5. Intact intracortical microstimulation (ICMS) representations of rostral and caudal forelimb areas in rats with quinolinic acid lesions of the medial or lateral caudate-putamen in an animal model of Huntington's disease.
Karl JM; Sacrey LA; McDonald RJ; Whishaw IQ
Brain Res Bull; 2008 Sep; 77(1):42-8. PubMed ID: 18639744
[TBL] [Abstract][Full Text] [Related]
6. Neocortical movement representations are reduced and reorganized following bilateral intrastriatal 6-hydroxydopamine infusion and dopamine type-2 receptor antagonism.
Brown AR; Hu B; Antle MC; Teskey GC
Exp Neurol; 2009 Nov; 220(1):162-70. PubMed ID: 19703443
[TBL] [Abstract][Full Text] [Related]
7. Sexually dimorphic postural adjustments during vertical behaviour are altered in a unilateral 6-OHDA rat model of Parkinson's disease.
Field EF; Metz GA; Pellis SM; Whishaw IQ
Behav Brain Res; 2006 Nov; 174(1):39-48. PubMed ID: 16930735
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.
Yuan H; Sarre S; Ebinger G; Michotte Y
Brain Res; 2004 Nov; 1026(1):95-107. PubMed ID: 15476701
[TBL] [Abstract][Full Text] [Related]
9. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.
Yuan H; Sarre S; Ebinger G; Michotte Y
J Neurosci Methods; 2005 May; 144(1):35-45. PubMed ID: 15848237
[TBL] [Abstract][Full Text] [Related]
10. Sequential bilateral striatal lesions have additive effects on single skilled limb use in rats.
Faraji J; Metz GA
Behav Brain Res; 2007 Feb; 177(2):195-204. PubMed ID: 17182115
[TBL] [Abstract][Full Text] [Related]
11. An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate.
Fleming SM; Delville Y; Schallert T
Behav Brain Res; 2005 Jan; 156(2):201-13. PubMed ID: 15582106
[TBL] [Abstract][Full Text] [Related]
12. Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions.
Quesada A; Micevych PE
J Neurosci Res; 2004 Jan; 75(1):107-16. PubMed ID: 14689453
[TBL] [Abstract][Full Text] [Related]
13. Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine.
Moroz IA; Peciña S; Schallert T; Stewart J
Exp Neurol; 2004 Sep; 189(1):78-93. PubMed ID: 15296838
[TBL] [Abstract][Full Text] [Related]
14. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.
Kirik D; Rosenblad C; Björklund A
Exp Neurol; 1998 Aug; 152(2):259-77. PubMed ID: 9710526
[TBL] [Abstract][Full Text] [Related]
15. Targeted motor rehabilitation dissociates corticobulbar versus corticospinal dysfunction in an animal model of Parkinson's disease.
Plowman EK; Maling N; Thomas NJ; Fowler SC; Kleim JA
Neurorehabil Neural Repair; 2014 Jan; 28(1):85-95. PubMed ID: 23921422
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent loss of motor function after unilateral medial forebrain bundle rotenone lesion in rats: a cautionary note.
Klein A; Gidyk DC; Shriner AM; Colwell KL; Tatton NA; Tatton WG; Metz GA
Behav Brain Res; 2011 Sep; 222(1):33-42. PubMed ID: 21419806
[TBL] [Abstract][Full Text] [Related]
17. Limits on recovery in the corticospinal tract of the rat: partial lesions impair skilled reaching and the topographic representation of the forelimb in motor cortex.
Piecharka DM; Kleim JA; Whishaw IQ
Brain Res Bull; 2005 Aug; 66(3):203-11. PubMed ID: 16023917
[TBL] [Abstract][Full Text] [Related]
18. Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease.
Reglodi D; Lubics A; Tamás A; Szalontay L; Lengvári I
Behav Brain Res; 2004 May; 151(1-2):303-12. PubMed ID: 15084446
[TBL] [Abstract][Full Text] [Related]
19. Experience-dependent amelioration of motor impairments in adulthood following neonatal medial frontal cortex injury in rats is accompanied by motor map expansion.
Williams PT; Gharbawie OA; Kolb B; Kleim JA
Neuroscience; 2006 Sep; 141(3):1315-26. PubMed ID: 16777345
[TBL] [Abstract][Full Text] [Related]
20. The unilateral 6-OHDA rat model of Parkinson's disease revisited: an electromyographic and behavioural analysis.
Metz GA; Tse A; Ballermann M; Smith LK; Fouad K
Eur J Neurosci; 2005 Aug; 22(3):735-44. PubMed ID: 16101755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
